International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-1 doi: 10.5281/zenodo.10578097
Original Article
Role of Neurosonography in Detecting Intracranial Abnormalities of Preterm Neonates
 ,
 ,
 ,
 ,
Published
Jan. 28, 2024
Abstract

Background: Preterm neonates face significant health challenges, with outcomes influenced by various maternal, neonatal and clinical factors. As the formation and maturation of central nervous system of preterm neonates is incomplete, they are more vulnerable to brain injury. In this study we have assessed the role of Neurosonography in early diagnosis of intracranial pathologies in preterm neonates.

Methods: This study involved a retrospective analysis of 100 preterm neonates admitted to Quaternary care hospital's NICU. We assessed demographic data, maternal and neonatal risk factors, clinical presentations, and neurosonography findings.

Results: The gender distribution was nearly equal (51% female, 49% male). Most neonates had a birth weight >1.5 kg (77%) and were ≤34.0 weeks gestation (54%). High prevalence of abnormal maternal risk factors was noted, including PPROM (28%), GDM (14%), and eclampsia (10%). Mechanical ventilation was required in 47% of cases. Common co-morbidities were RDS (37%), TTN (33%), and Neonatal Hyperbilirubinemia (27%). Neurosonography showed a high incidence of abnormalities (55%), with Germinal Matrix Hemorrhage (36%) and Cystic-Periventricular Leukomalacia (18%) being significant. A strong correlation was observed between lower birth weight, earlier gestation, and abnormal neurosonography findings (P values 0.038* and 0.033*).

Conclusion: There was moderately significant association between abnormal NSG and gestational age and birth weight. Most common intracranial abnormality detected through NSG was Germinal matrix haemorrhage and it carried the highest mortality. RDS, Severe RDS, TTN, Neonatal Sepsis, Neonatal hyperbilirubinemia had significant with abnormal NSG. This study concludes that early neurosonography in preterm neonates’ aids in predicting abnormal neurological outcome and preventing long term sequelae.

Recommended Articles
Loading Image...
Volume-5, Issue-1
Citations
301 Views
85 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved